Board member Bo Unéus has notified CS MEDICA A/S (”CS MEDICA” or the ”Company”) that he resigns as a member of the board of directors of CS MEDICA with immediate effect.

Copenhagen, Denmark, 25 October 2022: Board member Bo Unéus resigns as a board member with immediate effect of the board of directors of CS MEDICA and the company’s subsidiaries, CanNordic a/s and Galaxa Pharma a/s.

The remaining members of the board of directors constitute a quorum after Bo Unéus’s resignation and the appointment of any replacement director is expected to be considered in relation to the annual general meeting of CS MEDICA.

For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Tags: